938-05-6

Basic information

• Product Name: N,N-DIBROMOBENZENESULFONAMIDE
• Synonyms: N,N-DIBROMOBENZENESULFONAMIDE;N,N-Dibromobenzenesulfonimide;Dibromamine B
• CAS NO: 938-05-6
• Molecular Formula: C₆H₅Br₂NO₂S
• Molecular Weight: 314.98
• Mol File: 938-05-6.mol
• Article Data: 12

Chemical Properties

• Melting Point: 115 °C (decomp)
• Boiling Point: 351.5±25.0 °C(Predicted)
• Appearance: /
• Density: 2.123±0.06 g/cm3(Predicted)
• PKA: -27.85±0.70(Predicted)
• CAS DataBase Reference: N,N-DIBROMOBENZENESULFONAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: N,N-DIBROMOBENZENESULFONAMIDE(938-05-6)
• EPA Substance Registry System: N,N-DIBROMOBENZENESULFONAMIDE(938-05-6)

Safety Data

• Hazardous Substances Data: 938-05-6(Hazardous Substances Data)

Upstream product

• 16917-10-5 N-bromo-benzenesulfonamide; potassium-salt 
• 64-19-7 acetic acid 
• 98-10-2 benzenesulfonamide 
• 127-52-6 chloramine-B 

Downstream Products

• 19871-46-6 1-Benzenesulfonyl-2-phenyl-aziridine 
• 16917-09-2 bromamine B 
• 112564-08-6 N-[chlorodimethylstannyl]-N-(trimethylsilyl)benzenesulfonamide 
• 112564-09-7 N-[chlorodiethylstannyl]-N-(trimethylsilyl)benzenesulfonamide 
• 864448-25-9 (S)-ethyl 2-bromo-3-(N-((R)-2-bromo-3-ethoxy-3-oxopropyl)phenyl-sulfonamido)propanoate 
• 1214249-93-0 9-methyl-3-(phenylsulfonyl)-7-oxa-3,9-diaza-bicyclo[3.3.1]nonane 
• 1214249-92-9 3-(phenylsulfonyl)-7-oxa-3,9-diaza-bicyclo[3.3.1]nonane 

Relevant articles and documents

-

-

ALKYLATED PIPERAZINE COMPOUNDS

Alkylated piperazine compounds of Formula I are provided, including stereoisomers, tautomers, and pharmaceutically acceptable salts thereof, useful for inhibiting Btk kinase, and for treating immune disorders such as inflammation mediated by Btk kinase. Methods of using compounds of Formula I for in vitro, in situ, and in vivo diagnosis, and treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.

Palladium(II)-catalyzed oxidation of tranexamic acid by bromamine-B in alkaline medium and uncatalyzed reaction in acid medium: A study of kinetic and mechanistic chemistry

Tranexamic acid (TA) possess antifibrinolytic properties and finds extensive applications in pharmaceuticals. Its oxidation-kinetic study is of much significance in understanding the mechanistic profile of TA in biological systems. In this context, a systematic kinetic study of palladium(II) (Pd(II)) catalyzed oxidation of TA by sodium N-bromobenzenesulfonamide or bromamine-B (BAB) in alkaline medium and uncatalyzed reaction in perchloric acid medium at 303 K was investigated. In acid medium, the reaction exhibits a first-order dependence of rate on [BAB]o and less than unity order dependence on [TA]o. The reaction rate shows inverse less than unity order dependence with respect to [H+]. In alkaline medium, the reaction shows first-order dependence on both [BAB]o and [Pd(II)] and zero-order with respect to [TA]o. The order with respect to [OH -] is less than unity. Activation parameters have been evaluated. The oxidation reactions are nearly 10-fold faster in acid medium in comparison with alkaline medium. In alkaline medium, the Pd(II) catalyzed reactions are about 6-fold faster than the uncatalyzed reaction. Further, the catalytic constant (KC) has been calculated at different temperatures and activation parameters with respect to Pd(II) catalyst have also been evaluated. The conjugate acid C6H5SO2NHBr and the anion C 6H5SO2N-Br of BAB have been postulated as the reactive oxidizing species in acid and alkaline media, respectively. The proposed mechanisms and derived rate laws are in agreement with the observed kinetics.